Abbott India Ltd.

NSE: ABBOTINDIA | BSE: 500488 | ISIN: INE358A01014 | Industry: Pharmaceuticals
| Falling Comet
26295.0000 -100.00 (-0.38%)
NSE Feb 20, 2026 15:31 PM
Volume: 7,695
 

logo
Abbott India Ltd.
16 May 2025
26295.00
-0.38%
ICICI Securities Limited
Abbott India’s (Abbott) revenue grew 12% YoY ahead of most MNCs (avg. growth of ~10% YoY and IPM growth of ~8% YoY in Q4FY25). Abbott’s growth was aided by healthy traction in its own brands along with key brands of Novo Nordisk like Rybelsus and Ryzodeg.
ICICI Direct decreased Buy price target of Abbott India Ltd. to 32150.0 on 13 Feb, 2026.
More from Abbott India Ltd.
Recommended